Risk of Hysterectomy at Time of Myomectomy

The Risk of Hysterectomy at Time of Myomectomy at Ain Shams University Hospital: A Retrospective Cohort Study.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07365969

Enrollment

293

Registered

2026-01-26

Start date

2024-12-15

Completion date

2025-10-15

Last updated

2026-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibroid Uterus, Hysterectomy, Myomectomy

Keywords

hysterectomy, myomectomy, fibroid uterus

Brief summary

Uterine fibroids are the commonest tumor affecting the female reproductive tract and many instances they are asymptomatic but in some women there does appear to be an association with heavy menstrual blood loss and possibly subfertility. Classically, treatment has been surgical with hysterectomy the most common approach for women who have completed their fertility and myomectomy for those who wish to conceive. The surgery can be carried out laparoscopically, vaginally and abdominally. The aim of this study is to evaluate the risk of hysterectomy at the time of myomectomy, and the associated 30-day postoperative morbidity.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* Women planned for abdominal myomectomy in the previous 4 years. * Availability of complete medical records for pre-, intra- and post-operative data.

Exclusion criteria

* Missing or lacking information in the patients records like preoperative assessment of the fibroid uterus. * Absence of operative notes and relevant data in the medical files.

Design outcomes

Primary

Measure	Time frame
Incidence of hysterectomy at time of myomectomy.	Jan 2020- Dec 2024

Secondary

Measure	Time frame	Description
Characteristics of the Myomas who required hysterectomy	Jan 2020- Dec 2024	number, site, size, Figo staging
Intraoperative complications	Jan 2020- Dec 2024	Anesthesia complication, organ injury, blood transfusion.
Postoperative complications	Jan 2020- Dec 2024	Anemia, hemorrhage, fever, wound infection, wound hematoma
Duration of hospital stay	Jan 2020- Dec 2024	in days
Reoperation	Jan 2020- Dec 2024	within 5 days of surgery
Readmission after discharge from the hospital	Jan 2020- Dec 2024	within 14 days

Countries

Egypt

Outcome results